Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis.
about
Azathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitisOral 5-aminosalicylic acid for induction of remission in ulcerative colitisUnfractionated or low-molecular weight heparin for induction of remission in ulcerative colitisMethotrexate for induction of remission in ulcerative colitisOral 5-aminosalicylic acid for induction of remission in ulcerative colitisAzathioprine and 6-mercaptopurine for maintenance of remission in ulcerative colitisUnfractionated or low-molecular weight heparin for induction of remission in ulcerative colitisUnfractionated or low-molecular weight heparin for induction of remission in ulcerative colitisMethotrexate for induction of remission in ulcerative colitisOmega 3 fatty acids (fish oil) for maintenance of remission in ulcerative colitisOptimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel diseaseBenefit-risk assessment of golimumab in the treatment of refractory ulcerative colitisImpact of thiopurines and anti-tumour necrosis factor therapy on hospitalisation and long-term surgical outcomes in ulcerative colitisOptimal management of steroid-dependent ulcerative colitisHow to predict clinical relapse in inflammatory bowel disease patientsInflammatory Bowel Disease: An Overview of Immune Mechanisms and Biological TreatmentsHepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel diseaseClassical and recent advances in the treatment of inflammatory bowel diseasesOptimization of the treatment with immunosuppressants and biologics in inflammatory bowel diseaseImpact of medical therapies on inflammatory bowel disease complication rateClinical relevance of endoscopic assessment of inflammation in ulcerative colitis: Can endoscopic evaluation predict outcomes?Thiopurines and inflammatory bowel disease: Current evidence and a historical perspectiveOptimizing the use of thiopurines in inflammatory bowel diseaseSystematic review with meta-analysis: infliximab and immunosuppressant therapy vs. infliximab alone for active ulcerative colitisTreatment efficacy and safety of low-dose azathioprine in chronic active ulcerative colitis patients: A meta-analysis and systemic review.Narrow-band imaging with magnifying endoscopy for Peyer's patches is useful in predicting the recurrence of remissive patients with ulcerative colitis.Timing of myelosuppression during thiopurine therapy for inflammatory bowel disease: implications for monitoring recommendationsLong term efficacy and safety of allopurinol and azathioprine or 6-mercaptopurine in patients with inflammatory bowel disease.The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patientsInflammatory Bowel Disease (IBD) pharmacotherapy and the risk of serious infection: a systematic review and network meta-analysisCurrent approaches to the management of new-onset ulcerative colitis.Defining quality indicators for best-practice management of inflammatory bowel disease in Canada.Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.European evidence-based Consensus on the management of ulcerative colitis: Current management.Purine analogues compared with mesalamine or 5-ASA for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis.Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease.Introducing vedolizumab to clinical practice: who, when, and how?Mucosal healing in inflammatory bowel disease-a true paradigm of success?Tacrolimus--finally!Efficacy and Safety of Long-Term Thiopurine Maintenance Treatment in Japanese Patients With Ulcerative Colitis
P2860
Q24185761-0E048E08-C1F0-42D6-9E03-ADC8D288F4A4Q24185876-6F550DDD-2578-4508-ACD2-2B24D05FC3CAQ24188013-2BE70BDE-7760-475C-871A-93819F5B54C5Q24194275-43170A46-0FDA-4A44-9AE1-48A7FE8783ECQ24198024-5E6215E5-1D25-44DA-9DD4-D644BFB03370Q24200757-DD746BF0-DABF-4AF5-9689-C90504636516Q24234403-DC645E5A-4EFD-4E51-A76D-837516425BD0Q24243052-A99BEFF7-10A0-4A1D-BB4A-712FA644FC2EQ24243284-E940EC55-3870-4C4C-9CAD-D8D444FA6E14Q24244006-9CD2FA15-D0F1-4728-B94B-51EA2DE453DFQ24631869-815B9A77-3632-45F0-9F00-F43DCF2AECF3Q26764801-428A4966-1832-4010-8A95-8E0FC5D5A734Q26771136-1A6FE845-3706-4C4D-AC5D-3B36F0BABC49Q26773203-22465855-1081-4330-B9A3-F6F253706FEBQ26774575-A90AD7F3-00EA-472A-8774-E498FFEF6C50Q26785537-1753B47E-773E-4E12-8424-3B9C1CFF82DFQ26827444-6952F633-41B7-410B-BB46-FD1764D038DCQ26861725-95ED2F06-CC0A-4AD9-8019-D7DCCBF38ECCQ26866940-302C9FE5-04AB-4F94-8F9A-6AE232B705B2Q26995479-2858D25C-5D44-4D99-9F68-5AD2AE9DEF05Q28072104-1DC0422E-337D-4997-8172-4AA618107C59Q28079644-ADC3DC89-65F2-49D9-882E-D7FC86F641E3Q28082687-C7211F14-BDB2-4A92-847C-217C887B3FE1Q28088683-1D43A5A2-6D76-41B9-AF6B-9B67AEE0CFEBQ30248815-AD32E040-9F7F-4C03-8F1F-A5A0C978F80FQ30826715-10466D80-390D-4DCC-AE48-24972C0D7506Q33385516-C06D6E74-5AF1-4222-B537-EBBB26F3FC7CQ33393356-BE9B7BEA-81B4-4C47-930E-A29F79A6CB6EQ33536129-A3F17153-8F48-4E9D-9E84-881E4A413340Q33564492-3EA5B37B-1B70-4952-A31D-579CEA40DF89Q33633288-E7C66EEE-5A4B-4E56-941F-73428EC24A22Q33725615-D1F4A31E-233E-468D-B9AA-D1424E789A88Q33819473-47E28549-ECB9-4866-817E-24ACAC824078Q34025054-C857DCBB-1F50-4A0F-A169-370AD8E6FF5AQ34340362-3F94B26B-4D68-4FB7-8F55-AE4B2446AFB8Q34647681-A786B128-E7B5-49DF-8891-0D74D48EDEE7Q35562290-35BCA2CB-B238-4885-B952-D9CA461538FAQ35749943-3AF1D841-67AC-4105-BC1A-62DFD6F5C6AAQ35768958-E94F00DB-7281-4594-B97B-1A115E94F9C6Q35777883-644FEB32-53FC-41D0-A9EC-0BF64C76E6F4
P2860
Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Randomised controlled trial of ...... dependent ulcerative colitis.
@ast
Randomised controlled trial of ...... dependent ulcerative colitis.
@en
type
label
Randomised controlled trial of ...... dependent ulcerative colitis.
@ast
Randomised controlled trial of ...... dependent ulcerative colitis.
@en
prefLabel
Randomised controlled trial of ...... dependent ulcerative colitis.
@ast
Randomised controlled trial of ...... dependent ulcerative colitis.
@en
P2093
P2860
P356
P1433
P1476
Randomised controlled trial of ...... dependent ulcerative colitis.
@en
P2093
P2860
P356
10.1136/GUT.2005.068809
P407
P577
2005-06-21T00:00:00Z